Transplanting islets for diabetes

Scientist

Volumn 20, Issue 5, 2006, Pages 43-48

  Shapiro, A M James ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646490267     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. E.A. Ryan et al., "Five-year follow-up after clinical islet transplantation," Diabetes, 54:2060-9, 2005.
2. A.B. Adams et al., "Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates," Diabetes, 51:265-70, 2002.
3. F. Vincenti et al., "Costimulation blockade with belatacept in renal transplantation," N Engl J Med, 353:770-81, 2005.
4. H. Johansson et al., "Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation," Am J Transplant, 6:305-12, February 2006.
5. W.L. Suarez-Pinzon et al., "Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet β-cells from pancreatic duct cells and an increase in functional β-cell mass," J Clin Endocrinol Metab, 90:3401-9, 2005.
6. G. Xu et al., "GLP-1/exendin-4 facilitates β-cell neogenesis in rat and human pancreatic ducts," Diabetes Res Clin Pract, 2006, in press.
7. S. Bonner-Weir, G.C. Weir, "New sources of pancreatic β-cells," Nat Biotechnol, 23:857-61, 2005.
8. Y. Dor et al., "Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation," Nature, 429:41-6, 2004.
9. B.J. Hering et al., "Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates," Nat Med, 12:301-3, March 2006.
10. K. Cardona et al., "Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways," Nat Med, 12:304-6, March 2006.